Cooperated Pipeline Product
| Number | Product | CAS | Indication | Patent | |
|---|---|---|---|---|---|
| 1 | Finerenone | 1050477-31-0 | Diabetic Chronic Kidney Disease | 2028-02 |
|
| 2 | Vericiguat | 1350653-20-1 | Chronic Heart Failure | 2031-05 |
|
| 3 | Fezolinetant | 1629229-37-3 | Vasomotor Symptoms | 2034-03 |
|
Self-Developed Products
| Number | Product | CAS | Indication | Status | |
|---|---|---|---|---|---|
| 1 | Cabozantinib | 849217-68-1 | Advanced Renal Cell Carcinoma/Hepatocellular Carcinoma | PV / FDA (DMF # 039757) |
|
| 2 | Cytisine | 485-35-8 | Smoking Cessation | WC / PV / FDA (DMF # 039649) |
|
| 3 | 7-Ethyl-10-hydroxycamptothecin | 130144-34-2 | Triple-negative Breast Cancer | PV / FDA (DMF # 039576) |
|
| 4 | Resmetirom | 920509-32-6 | Noncirrhotic Nonalcoholic Steatohepatitis | Pilot / FDA (DMF # 040872) |
|
| 5 | Darolutamide | 1297538-32-9 | Non-metastatic Castration-Resistant Prostatic Cancer | Pilot |
|
| 6 | Indigo Carmine | 860-22-0 | Diagnostic Dye | Pilot |
|
| 7 | Osimertinib | 1421373-66-1 | EGFR-mutated non-small Cell lung cancer | Pilot |
|
| 8 | Abemaciclib | 1231929-97-7 | Breast Cancer | Pilot |
|
| 9 | Conjugated Estrogens (Synthesis) | 12126-59-9 | Estrogen Supplements | Pilot |
|
| 10 | Ingenol Mebutate | 75567-37-2 | ActinicKeratosis | Pilot |
|
| 11 | Birch Triterpenes | 1640971-03-4 | Epidermolysis Bullosa | Pilot |
|
| 12 | Nilotinib | 641571-10-0 | Ph+ CML | DMF / GMP |
|
| 13 | Dasatinib | 302962-49-8 | Ph+ CML/Ph+ ALL | DMF / GMP |
|
| 14 | Cabazitaxel | 183133-96-2 | Anti-tumor/Metastatic Prostate Cancer | DMF / GMP |
|
